Effect of tSCS on Ankle Movement Training in Individuals With SCI
1 other identifier
interventional
80
1 country
1
Brief Summary
This clinical trial explores the effectiveness of transcutaneous spinal cord stimulation (tSCS), a non-invasive technique, in facilitating spinal circuitry adaptation in individuals with spinal cord injury (SCI). While epidural spinal cord stimulation (eSCS) has shown functional benefits, its application is limited by the side effects associated with implanted electrodes. tSCS, which shares a similar mechanism but does not require surgery, has yet to be extensively studied in large human trials. The study aims to: Determine optimal tSCS parameters for non-invasive spinal stimulation. Investigate the priming effect of tSCS on spinal circuitry during machine-assisted ankle movement training. Examine the long-term clinical outcomes of combining tSCS with ankle movement training in individuals with incomplete SCI. The trial will include both healthy participants and individuals with complete and incomplete SCI, using the soleus post-activation depression (PAD) model to evaluate spinal circuitry adaptation. The results will provide insights into spinal re-adaptation and potentially introduce a novel, non-invasive approach for SCI rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
November 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
November 26, 2024
November 1, 2024
1.7 years
September 11, 2024
November 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Latency and amplitude of the H-reflex
The H-reflex will be elicited through electrical stimulation of the tibial nerve (or sciatic nerve) using electromyography (EMG) to record the resulting muscle response.
Baseline, 4 weeks
Latency, amplitude, and duration of the M-wave
The M-wave will be elicited by direct electrical stimulation of the motor nerve (e.g., tibial nerve) and recorded using electromyography (EMG) from the target muscle (e.g., soleus muscle).
Baseline, 4 weeks
Level of Post-Activation Depression (PAD) of the H-reflex
The H-reflex will be elicited by electrical stimulation of the tibial nerve (or other motor nerves), and PAD will be assessed by measuring the reduction in H-reflex amplitude following a series of repetitive stimuli. The amplitude of the H-reflex after repeated stimulation will be compared to the baseline single stimulus.
Baseline, 4 weeks
Latency and amplitude of the Posterior Root Muscle (PRM) reflex
The PRM reflex will be elicited by stimulating the posterior roots of the spinal cord (typically via electrical stimulation of the dorsal roots), and the resulting muscle activity will be recorded using electromyography (EMG)
Baseline, 4 weeks
Muscle spasticity levels as assessed by the Modified Ashworth Scale (MAS).
Muscle spasticity will be evaluated using the MAS, which grades the resistance encountered during passive movement of the affected limb (e.g., arm or leg). The scale ranges from 0 (no increase in muscle tone) to 4 (affected part rigid in flexion or extension).
Baseline, 4 weeks
Muscle Tone (Frequency, Hz)
This parameter measures the natural oscillation frequency of the muscle in response. It reflects the muscle's state of tension or readiness.
Baseline, 4 weeks
Elasticity (Dynamic Stiffness, N/m)
Elasticity, measured in Newtons per meter, reflects the muscle's ability to return to its original shape after being deformed by the impulse
Baseline, 4 weeks
Stiffness (Decay, ms)
This parameter quantifies the rate at which the muscle returns to its initial state after the impulse, indicating the muscle's stiffness
Baseline, 4 weeks
Mechanical Stress (Creep, s) and Relaxation (S)
These parameters measure the time it takes for muscle tissue to adapt to a sustained force (creep) and the time it takes for the muscle to return to a relaxed state after removing the force (relaxation).
Baseline, 4 weeks
Secondary Outcomes (5)
Foot pressure distribution and peak pressure.
Measured continuously during CPM
The score of 10-meter walking test (10MWT)
Baseline, 4 weeks.
Ankle Joint Range of Motion (ROM)
Baseline, 4 weeks
Knee Joint ROM
Baseline, 4 weeks
Overall the Patient Reported Impact of Spasticity Measure(PRISM) Score
Baseline, 4 weeks
Study Arms (4)
Stage 1: Healthy people
EXPERIMENTALIdentify optimal tSCS parameters for non-invasive spinal stimulation.
Stage 2: SCI Patients
EXPERIMENTALAssess the priming effect of tSCS on spinal circuitry during machine-assisted ankle movement training.
Stage 3:SCI Patients
EXPERIMENTALLong-term clinical effects of combined tSCS and ankle movement training
Stage 3:SCI Patients(Control)
NO INTERVENTIONControl Group
Interventions
The subjects will undergo 20 minutes transcutaneous spinal cord stimulation (tSCS).
The subjects will undergo 30 minutes of machine-assisted ankle movement training combined with transcutaneous spinal cord stimulation (tSCS) at a time
The subjects will undergo machine-assisted ankle movement training combined with transcutaneous spinal cord stimulation (tSCS). Each session will last for 30 minutes, conducted three times per week, over a period of four weeks.
Eligibility Criteria
You may not qualify if:
- Musculoskeletal injuries on legs.
- Osteoporosis.
- SCI subjects:
- \. Participants with chronic spinal cord injury, with injury duration greater than one year.
- Current musculoskeletal or joint injuries in the lower limbs.
- History of central or peripheral neuromuscular diseases.
- Presence of a pacemaker.
- Current use of antispastic or antidepressant medications.
- Current venous thromboembolism or osteoporosis.
- Impairment of the soleus H-reflex arc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung University
Taoyuan District, 333, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 11, 2024
First Posted
September 19, 2024
Study Start
November 25, 2024
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
November 26, 2024
Record last verified: 2024-11